Wen Hsiang Lai
Chairman at CENTURY IRON AND STEEL INDUSTRIAL CO.,LTD.
Net worth: 85 M $ as of 30/03/2024
Network origin in Wen Hsiang Lai first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Building Products | 17 | |
Public Company | Alternative Power Generation | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wen Hsiang Lai via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CHINA STEEL CORPORATION | Steel | Director/Board Member | |
TAIWAN GLASS IND. CORP. | Industrial Specialties | Director/Board Member | |
FORMOSA TAFFETA CO., LTD. | Textiles | Chief Executive Officer | |
KENDA RUBBER INDUSTRIAL CO. LTD. | Automotive Aftermarket | Director/Board Member | |
HSIN KUANG STEEL COMPANY LIMITED | Steel | Chief Executive Officer | |
FARCENT ENTERPRISE CO.,LTD | Household/Personal Care | Director/Board Member | |
NORTH-STAR INTERNATIONAL CO., LTD. | Specialty Stores | Director/Board Member | |
University of Tamkang | College/University | Undergraduate Degree | |
National Taiwan University | College/University | Graduate Degree | |
National Chung Hsing University | College/University | Undergraduate Degree | |
SWANCOR HOLDING CO., LTD. | Chemicals: Specialty | Director/Board Member | |
SIMULA TECHNOLOGY INC. | Electronic Components | Director/Board Member | |
Yi Chou Group | Chairman | ||
UWELL Biopharma, Inc.
UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Director/Board Member | |
Yi-Chiu International Development Co. Ltd.
Yi-Chiu International Development Co. Ltd. Financial ConglomeratesFinance Yi-Chiu International Development Co. Ltd. is a Taiwanese company that provides investment and management consulting services. The private company is based in New Taipei, Taiwan. The company was founded in 2012. | Financial Conglomerates | Director/Board Member | |
Century Huaxin Wind Energy Co. Ltd.
Century Huaxin Wind Energy Co. Ltd. SteelNon-Energy Minerals Century Huaxin Wind Energy Co. Ltd. is a Taiwanese company that engages in iron and steel processing. The private company is based in Taoyuan City, Taiwan. The company was founded in 2020. The CEO is Kuo Chih Huang. | Steel | Director/Board Member | |
YI CHUN GREEN TECHNOLOGY CO., LTD. | Environmental Services | Chairman |
Statistics
International
Taiwan | 18 |
Sectoral
Non-Energy Minerals | 4 |
Process Industries | 4 |
Consumer Services | 4 |
Consumer Durables | 2 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 33 |
Independent Dir/Board Member | 14 |
Chief Executive Officer | 5 |
Chairman | 4 |
Public Communications Contact | 4 |
Most connected contacts
Insiders | |
---|---|
Chia Hung Chin | 8 |
Sheng Chung Lin | 6 |
Ming Te Su | 4 |
Chin Chi Chen | 2 |
Tien Cheng Yang | 2 |
Kuang Ming Li | 2 |
Ming Te Li | 2 |
Chun Fu Chang | 1 |
En Guang Mao | 1 |
Sheng Yuan Qu | 1 |
Hsuan Pin Lai | 1 |
Huei Hua Lai | 1 |
Kuo Chin Chen | 1 |
Yu Ling Zhang | 1 |
Ming Zheng Lin | 1 |
- Stock Market
- Insiders
- Wen Hsiang Lai
- Company connections